Coastwise Capital Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $322K | Buy |
1,734
+11
| +0.6% | +$2.04K | 0.26% | 86 |
|
2025
Q1 | $361K | Sell |
1,723
-58
| -3% | -$12.2K | 0.3% | 78 |
|
2024
Q4 | $316K | Buy |
1,781
+12
| +0.7% | +$2.13K | 0.25% | 89 |
|
2024
Q3 | $349K | Buy |
1,769
+294
| +20% | +$58.1K | 0.29% | 87 |
|
2024
Q2 | $253K | Buy |
1,475
+101
| +7% | +$17.3K | 0.24% | 94 |
|
2024
Q1 | $250K | Buy |
1,374
+9
| +0.7% | +$1.64K | 0.23% | 102 |
|
2023
Q4 | $212K | Buy |
+1,365
| New | +$212K | 0.22% | 105 |
|
2023
Q1 | – | Sell |
-1,750
| Closed | -$283K | – | 112 |
|
2022
Q4 | $283K | Sell |
1,750
-81
| -4% | -$13.1K | 0.34% | 86 |
|
2022
Q3 | $246K | Buy |
1,831
+12
| +0.7% | +$1.61K | 0.39% | 80 |
|
2022
Q2 | $279K | Sell |
1,819
-109
| -6% | -$16.7K | 0.34% | 81 |
|
2022
Q1 | $312K | Buy |
+1,928
| New | +$312K | 0.39% | 73 |
|